-
New hypothesis proposes that Alzheimer’s is principally a disorder of the immune system within the brain. This, given alleged fabricated data in paper published in Nature in 2006, linking beta-amyloid as the causative agent.
Medical Mythbusting Commentary for September 21, 2022 Source:Alzheimer’s Might Not Actually Be a Brain Disease, Expert Says Reference:Alzheimer’s disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites
-
Phase 2 study demonstrates that a new blood plasma Alzheimer biomarker may assist in earlier diagnosis of Alzheimer’s disease
Medical Mythbusting Commentary for April 26, 2022 Source:New Alzheimer’s Biomarker May Facilitate Rapid Diagnosis Reference:A possible blood plasma biomarker for early-stage Alzheimer’s disease
-
Alzheimer’s prevention Phase 1 trial will look at safety of nasal vaccine. Much to happen before any conclusions can be drawn from this study. Also, @billcarrolltalk and I also discuss the approval of COVID vaccine for 5-11 year-old children.
Medical Mythbusting Commentary for November 22, 2021 Source:Nasal vaccine to treat Alzheimer’s disease to be tested in U.S. clinical trial COVID-19 vaccines for children
-
FDA approval process questioned as it approves new early-stage $56K US/year treatment for Alzheimer’s despite its own panel founding insufficient evidence of efficacy. Only when company changed the study endpoint did it show efficacy compared to placebo.
Medical Mythbusting Commentary for June 8, 2021 Source:In controversial decision, FDA approves first new Alzheimer’s disease drug in nearly 20 years
-
Unpublished study begets questions about the neurological basis why having a “paying job” may help fend off Alzheimer’s in women.
Health Headlines Commentary for July 23, 2019 Source:Having a paying job may help fend off Alzheimer’s disease in women Reference:Presented their findings at the Alzheimer’s Association International Conference recently in Los Angeles.
-
There is no evidence from this study to suggest that antidepressants can triple the risk of people developing dementia.
Health Headlines Commentary for June 12, 2019 Source:Older people taking antidepressants could triple their risk of developing dementia: Study Reference:Exposure to Antidepressant Medication and the Risk of Incident Dementia
-
Ketogenic drink may help curb mild cognitive impairment due to Alzheimer’s disease but then again it may not. Only 52 people involved in this small study.
Health Headlines Commentary for May 27, 2019 Source: Ketone drink may one day fight Alzheimer’s disease and dementia Reference: A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment
-
Retinal eye exam study for the early detection of Alzheimer’s has his limitations and requires larger study populations to evaluate whether this is an effective screening test
Health Headlines Commentary for August 29, 2018 Source: Simple eye exam may be able to screen for Alzheimer’s: study Reference: Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings
-
Excellent basic science study looks at certain viruses as a contributing factor to the development of Alheimer’s
Health Headlines Commentary for June 22, 2018 Source: New evidence that viruses may play a role in Alzheimer’s Reference: Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus